Skip to main content
Log in

Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII

  • CE - Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Sallah S, Husain A, Nguyen-Nam P (2004) Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation. Blood Coagul Fibrinolysis 15(7):577–582

    PubMed  CAS  Google Scholar 

  2. Malone DL, Dune J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM (2003) Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54:898–907

    Article  PubMed  Google Scholar 

  3. Von Depka M. Novoseven (2002) Mode of action and use in acquired haemophilia. Intensive Care Med 28:222–227

    Article  Google Scholar 

  4. Kenet G, Walden R, Eldad A, Martinowitz U (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879

    Article  PubMed  CAS  Google Scholar 

  5. Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, Lynn M (2001) Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 51:431–439

    PubMed  CAS  Google Scholar 

  6. Grounds M (2003) Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review. Blood Rev 17:11–21

    Article  Google Scholar 

  7. Friederich PW, Henny CP, Messelink FJ, Geerdink MG, Keller T, Kurth KH, Buller HR, Levi M (2003) Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 361:201–205

    Article  PubMed  CAS  Google Scholar 

  8. Deveras RA, Kessler CM (2002) Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 137:884–888

    PubMed  CAS  Google Scholar 

  9. Hedner U. Recombinant factor VIIa (Novoseven) as a hemostatic agent. Dis Mon 49:39–48

  10. Roberts HR, Monroe DM, White GC (2004) The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 104:3858–3864

    Article  PubMed  CAS  Google Scholar 

  11. Hoffman M (2003) A cell-based model of coagulation and the role of factor VIIa. Blood Rev 17(Suppl 1):1–5

    Article  Google Scholar 

  12. Roberts HR (2001) Factor VIIa and the safety of treatment. Semin Hematol 38(suppl 12):48–50

    Article  PubMed  CAS  Google Scholar 

  13. Levi M (2003) Safety of recombinant factor VIIa. TATM 5:11–14

    Google Scholar 

  14. Martinowitz U, Michaelson M (2005) Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli multidisciplinary rFVIIa task force. J Thromb Haemost 3:640–648

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nikolaos Gombakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hatzipantelis, E.S., Gombakis, N., Sidi, V. et al. Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII. Intern Emerg Med 3, 171–173 (2008). https://doi.org/10.1007/s11739-008-0104-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-008-0104-8

Keywords

Navigation